-
-
-
-
-
-
-
Quantum BioPharma gets FDA nod for Lucid-MS Phase 2 MS trial
-
-
-
-
-
-
-
MiNK Therapeutics reports Q2 2026 results and Phase 2 trial data
-
-
-
-
-
-
-
BAE Systems advances to Phase 2 of DARPA's THREADS program
-
-
-
-
-
-
-
Sutro Biopharma posts Q2 loss, reports early STRO-004 trial data
-
-
-
-
-
-
-
Big Sky Industrial posts Q2 loss, advances helium plant construction
-
-
-
-
-
-
-
NeOnc to release NEO100 Phase 2a trial data on August 12
-
-
-
-
-
-
-
Spyre Therapeutics launches SPY772 program and Phase 2 trial in HS
-
76,670 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.

